Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 09, 2024 04:05 pm ET

Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.

Mar 18, 2024 09:05 am ET

Parexel Announces CEO Succession Plan

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced that Jamie Macdonald will retire and transition his role as Chief Executive Officer...

Mar 06, 2024 12:46 am ET

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $250.0 million aggregate principal amount of notes. Tandem also granted the initial purchasers of

Mar 04, 2024 04:05 pm ET

Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $250.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Tandem also intends to grant the initial purchasers of the notes an option to purchase, within the 13-day period

Feb 21, 2024 04:05 pm ET

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2023 and provided its financial guidance for the year ending December 31, 2024.

Feb 13, 2024 08:30 am ET

Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living with diabetes.* The company has begun taking orders and shipping to eligi

Feb 08, 2024 04:05 pm ET

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

Jan 22, 2024 04:05 pm ET

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2023 results after the financial markets close on Wednesday, February 21, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2023 financial and operating results.

Jan 08, 2024 08:00 am ET

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

Abbott (NYSE: ABT), the global health care company, and Tandem Diabetes Care, Inc. (NASDAQ: TNDM)

Dec 12, 2023 04:15 pm ET

Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now available for all Tandem pump users and their HCPs in the United States, with international availability expected in 2024.

Dec 06, 2023 08:30 am ET

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 Continuous Glucose Monitoring (CGM) integration in the United States. Tandem’s #1-rated automated insulin delivery (AID) system* with Control-IQ technology is the only AID option in the world today to use Dexcom’s latest CGM technology.

Nov 07, 2023 03:47 pm ET

Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline

The Portnoy Law Firm advises Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) investors that a lawsuit filed on behalf of investors that purchased Tandem securities between August 3, 2022 and November 2, 2022, inclusive (the...

Nov 07, 2023 03:43 pm ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

Attention Tandem Diabetes Care, Inc. ("Tandem") (NASDAQ: TNDM) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between August 3, 2022 and November 2, 2022. If...

Nov 07, 2023 01:26 pm ET

TNDM DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

NEW YORK, Nov. 7, 2023 /PRNewswire/ --

Nov 07, 2023 12:45 pm ET

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Nov 06, 2023 04:05 pm ET

Tandem Diabetes Care Announces Upcoming Conference Presentations

Nov 06, 2023 12:15 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

Levi & Korsinsky, LLP notifies investors in Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Tandem investors who were...

Nov 06, 2023 11:50 am ET

TNDM DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the “Class Period”), of the important...

Nov 06, 2023 11:00 am ET

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ:

Nov 06, 2023 10:12 am ET

DEADLINE ALERT for PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Nov 06, 2023 04:45 am ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

NEW YORK, Nov. 6, 2023 /PRNewswire/ -- Attention Tandem Diabetes Care, Inc. ("Tandem") (NASDAQ: TNDM) shareholders:

Nov 06, 2023 02:00 am ET

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Nov 05, 2023 04:51 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....

Nov 05, 2023 04:45 pm ET

TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TNDM

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, all dates inclusive (the “Class Period”), have until November 7, 2023 to...

Nov 03, 2023 11:40 pm ET

FINAL DEADLINE TUESDAY: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Nov 03, 2023 09:00 pm ET

TANDEM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or otherwise acquired Tandem securities between August 3, 2022 and November 2, 2022, both dates inclusive (the “Class Period”). Investors have until November 7, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Nov 03, 2023 08:00 pm ET

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Nov 03, 2023 03:36 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Nov 03, 2023 03:28 pm ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES, Nov. 3, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Nov 03, 2023 07:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Nov 02, 2023 02:52 pm ET

DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Nov 02, 2023 12:24 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 – (NASDAQ: TNDM)

The Gross Law Firm issues the following notice to shareholders of Tandem Diabetes Care, Inc. Shareholders who purchased shares of TNDM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...

Nov 02, 2023 05:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM) of a class action securities lawsuit.

Nov 02, 2023 02:30 am ET

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 2, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Nov 01, 2023 08:03 pm ET

Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline.

Nov 01, 2023 04:06 pm ET

Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for nearly 25 years.

Nov 01, 2023 04:02 pm ET

Tandem Diabetes Care Announces Third Quarter 2023 Financial Results

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2023 and updated its financial guidance for the year ending December 31, 2023.

Nov 01, 2023 12:30 pm ET

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline

Bernstein Liebhard LLP: Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?Did you purchase your shares between August 3, 2022 and November 2, 2022, inclusive?Did you lose money in your investment in Tandem Diabetes Care,...

Nov 01, 2023 12:24 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. (TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

Nov 01, 2023 08:30 am ET

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TNDM

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the “Class Period”), have until November 7, 2023...

Nov 01, 2023 03:30 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 1, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 31, 2023 07:56 pm ET

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM

Oct 31, 2023 03:39 pm ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Oct. 31, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 31, 2023 12:24 pm ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

Oct 31, 2023 11:37 am ET

DEADLINE ALERT for PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Oct 31, 2023 07:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 31, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 31, 2023 05:45 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM)

NEW YORK, Oct. 31, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Tandem Diabetes Care, Inc..

Oct 30, 2023 01:47 pm ET

TNDM NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

NEW YORK, Oct. 30, 2023 /PRNewswire/ --

Oct 30, 2023 01:00 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 – (NASDAQ: TNDM)

Oct 30, 2023 11:03 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Tandem Diabetes Care, Inc....

Oct 30, 2023 10:45 am ET

UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, Oct. 30, 2023 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ: TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 30, 2023 08:43 am ET

TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: TNDM) and certain of its officers.

Oct 30, 2023 05:45 am ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- Attention Tandem Diabetes Care, Inc. ("Tandem") (NASDAQ: TNDM) shareholders:

Oct 30, 2023 03:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 30, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 29, 2023 09:00 pm ET

TANDEM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm

Oct 29, 2023 06:21 am ET

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 27, 2023 07:47 pm ET

ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM

Oct 27, 2023 01:07 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

Oct 27, 2023 12:26 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Oct 27, 2023 11:00 am ET

DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Oct 27, 2023 06:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 26, 2023 12:31 pm ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

Oct 26, 2023 05:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Oct. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM) of a class action securities lawsuit.

Oct 25, 2023 11:45 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 25, 2023 08:19 pm ET

TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ: TNDM) and certain of its officers.

Oct 25, 2023 05:19 pm ET

TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Oct 25, 2023 03:27 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Oct 25, 2023 12:46 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 – (NASDAQ: TNDM)

Oct 25, 2023 11:00 am ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 25, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 24, 2023 12:07 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Oct 24, 2023 05:45 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM)

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Tandem Diabetes Care, Inc..

Oct 24, 2023 04:18 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 24, 2023 01:45 am ET

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline

– Bernstein Liebhard LLP: Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?Did you purchase your shares between August 3, 2022 and November 2, 2022, inclusive?Did you lose money in your investment in Tandem Diabetes...

Oct 23, 2023 09:00 pm ET

TANDEM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm

Oct 23, 2023 02:19 pm ET

ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

NEW YORK, Oct. 23, 2023 /PRNewswire/ --

Oct 23, 2023 11:00 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Oct 23, 2023 05:45 am ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Attention Tandem Diabetes Care, Inc. ("Tandem") (NASDAQ: TNDM) shareholders:

Oct 23, 2023 04:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 23, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 21, 2023 03:32 pm ET

ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Oct 21, 2023 10:34 am ET

TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline

Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (“Tandem Diabetes Care” or the “Company”) a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on behalf of investors who acquired securities within the class period. Investors are encouraged to review the following information.

Oct 20, 2023 12:27 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 – (NASDAQ: TNDM)

Oct 20, 2023 11:00 am ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 20, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 20, 2023 09:58 am ET

TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline

Oct 20, 2023 06:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 19, 2023 12:57 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. (TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

Oct 19, 2023 12:07 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Oct 19, 2023 11:00 am ET

DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Oct 19, 2023 06:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 19, 2023 05:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Oct. 19, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM) of a class action securities lawsuit.

Oct 18, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DFS, UiPath, and Tandem and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Discover Financial Services (NYSE: DFS), UiPath, Inc. (NYSE: PATH), and Tandem...

Oct 18, 2023 12:12 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Oct 18, 2023 06:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ: TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 17, 2023 11:54 pm ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Oct. 17, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 17, 2023 02:40 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Oct 17, 2023 05:10 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 17, 2023 01:45 am ET

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline

Oct 16, 2023 05:33 pm ET

ROSEN, A LEADING NATIONAL FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

NEW YORK, Oct. 16, 2023 /PRNewswire/ --

Oct 16, 2023 01:24 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Oct 16, 2023 05:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 16, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 14, 2023 07:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 13, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DFS, UiPath, and Tandem and Encourages Investors to Contact the Firm

Oct 13, 2023 09:48 am ET

TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline

Oct 13, 2023 09:37 am ET

DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Oct 13, 2023 06:00 am ET

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 11, 2023 11:30 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 11, 2023 12:00 pm ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 11, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 11, 2023 11:47 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Oct 11, 2023 05:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 10, 2023 04:05 pm ET

Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results after the financial markets close on Wednesday, November 1, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2023 financial and operating results.

Oct 10, 2023 03:25 pm ET

ROSEN, A LONGSTANDING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Oct 10, 2023 12:12 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Oct 10, 2023 07:00 am ET

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline

Oct 10, 2023 05:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 10, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 09, 2023 03:36 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Oct 09, 2023 12:00 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Oct 09, 2023 03:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 9, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 08, 2023 10:08 pm ET

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

NEW YORK, Oct. 8, 2023 /PRNewswire/ --

Oct 08, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie’s and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Care, Inc. (NASDAQ: TNDM), and...

Oct 07, 2023 07:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 06, 2023 12:00 pm ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 6, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 06, 2023 10:02 am ET

TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline

Oct 06, 2023 06:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 05, 2023 07:12 pm ET

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Oct 05, 2023 02:59 pm ET

Tandem Diabetes Care, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Tandem Diabetes Care, Inc.; Contact Robbins LLP Today

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022. Tandem is a...

Oct 05, 2023 12:15 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Oct 05, 2023 09:30 am ET

DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Oct 04, 2023 11:45 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 4, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 04, 2023 04:30 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 4, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 03, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tandem, Leslie’s, and PacWest and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Leslie’s, Inc. (NASDAQ: LESL), and...

Oct 03, 2023 12:45 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Oct 03, 2023 09:00 am ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Oct. 3, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Oct 03, 2023 04:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Oct 03, 2023 01:45 am ET

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline

Oct 02, 2023 01:02 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Oct 01, 2023 11:30 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 1, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 30, 2023 07:00 pm ET

Lifshitz Law PLLC Announces Investigations of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Leslie’s, Inc. (NASDAQ: LESL), and PacWest Bancorp (NASDAQ: PACW)

UiPath, Inc. (NYSE: PATH) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or...

Sep 29, 2023 08:33 pm ET

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Sep 29, 2023 05:03 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Sep 29, 2023 02:00 pm ET

DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Sep 28, 2023 11:45 pm ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 28, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tandem, Leslie’s, and PacWest and Encourages Investors to Contact the Firm

Sep 28, 2023 04:03 pm ET

ROSEN, A LONGSTANDING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

NEW YORK, Sept. 28, 2023 /PRNewswire/ --

Sep 28, 2023 12:12 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Sep 28, 2023 11:05 am ET

TNDM Shareholders Who Have Lost Money in the Stock Should Contact Robbins LLP for Information About the Class Action Against Tandem Diabetes Care, Inc.

Sep 28, 2023 05:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 27, 2023 04:13 pm ET

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES, Sept. 27, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM).

Sep 27, 2023 11:50 am ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 26, 2023 11:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 25, 2023 06:47 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Sep 25, 2023 12:30 pm ET

TANDEM DIABETES CARE, INC. (NASDAQ: TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc.

Sep 25, 2023 12:00 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 25, 2023 11:00 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Sep 25, 2023 10:35 am ET

Johnson Fistel Announces a Class Action Lawsuit has been Filed Against Tandem Diabetes Care

Sep 24, 2023 03:00 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ: TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 23, 2023 07:09 pm ET

Lifshitz Law PLLC Announces Investigations of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Leslie’s, Inc. (NASDAQ: LESL), and PacWest Bancorp (NASDAQ: PACW)

Sep 23, 2023 08:42 am ET

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Sep 22, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie’s and Encourages Investors to Contact the Firm

Sep 22, 2023 12:49 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Sep 22, 2023 12:16 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Sep 21, 2023 10:10 pm ET

TNDM SHAREHOLDER ALERT: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

NEW YORK, Sept. 21, 2023 /PRNewswire/ --

Sep 21, 2023 06:52 pm ET

TNDM Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Recovery Against Tandem Diabetes Care, Inc.

Sep 21, 2023 05:38 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Sep 21, 2023 09:00 am ET

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Law Offices of Howard G. Smith reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) securities between August 3, 20222 and November 2, 2022, inclusive (the “Class Period”).

Sep 21, 2023 07:45 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 20, 2023 07:00 am ET

TANDEM DIABETES CARE, INC. (NASDAQ: TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc.

Sep 19, 2023 01:12 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ:

Sep 19, 2023 08:15 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 18, 2023 03:40 pm ET

Tandem Diabetes Care, Inc. (TNDM) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Tandem Diabetes Care, Inc. Securities Fraud Class Action

Sep 18, 2023 01:05 pm ET

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ:

Sep 18, 2023 11:45 am ET

TNDM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, both dates inclusive (the “Class Period”) have until November 7, 2023 to seek appointme

Sep 18, 2023 09:30 am ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) securities between August 3, 20222 and November 2, 2022, inclusive (the “Class Period”). Tandem investors have until November 7, 2023 to file a l

Sep 18, 2023 06:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 17, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie’s and Encourages Investors to Contact the Firm

Sep 17, 2023 07:30 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ: TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 16, 2023 02:20 pm ET

TNDM INVESTOR ALERT: Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Sept. 16, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the "Class Period") have until November 7, 2023 to seek appointment as lead plaintiff of the Tandem Diabetes class action lawsuit. Captioned Lowe v. Tandem Diabetes Care, Inc., No. 23-cv-01657 (S.D. Cal.), the Tandem Diabetes class action lawsuit charges Tandem Diabetes and certain of its top executive officers with violations of the Securities Exchange Act of 1934.

Sep 15, 2023 06:26 pm ET

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

Sep 15, 2023 01:52 pm ET

Tandem Diabetes Care, Inc. (TNDM) Investor Alert: Robbins LLP Reminds Investors of Class Action Filed Against Tandem Diabetes Care, Inc.

Sep 15, 2023 01:16 pm ET

DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Sep 15, 2023 11:00 am ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ:

Sep 15, 2023 06:00 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 14, 2023 07:49 pm ET

TOP RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

NEW YORK, Sept. 14, 2023 /PRNewswire/ --

Sep 14, 2023 04:45 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) investors concerning the Company’s possible violations of federal securities laws.

Sep 14, 2023 06:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 13, 2023 05:03 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Sep 13, 2023 02:38 pm ET

The Law Offices of Frank R. Cruz Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ:

Sep 12, 2023 11:30 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 12, 2023 07:50 pm ET

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TNDM

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 7, 2023.

Sep 12, 2023 05:58 pm ET

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. (TNDM)

Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired Tandem...

Sep 12, 2023 12:38 pm ET

TNDM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Sep 12, 2023 04:30 am ET

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 12, 2023 04:00 am ET

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Sep 12, 2023 01:45 am ET

TANDEM DIABETES CARE, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. (NASDAQ: TNDM)

Sep 11, 2023 09:00 pm ET

TANDEM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or otherwise acquired Tandem securities between August 3, 2022 and November 2, 2022, both dates inclusive (the “Class Period”). Investors have until November 7, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Sep 11, 2023 08:05 pm ET

TNDM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead the Tandem Diabetes Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the “Class Period”) have until November 7, 2023 to seek appointment as lead

Sep 11, 2023 04:19 pm ET

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Tandem Diabetes Care, Inc.

Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022. Tandem is a global medical technology company that develops, manufactures, and markets a variety of

Sep 11, 2023 12:59 pm ET

Class Action Lawsuit Filed on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors - Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Cont

Holzer & Holzer, LLC informs investors that a class action lawsuit has been filed against Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: TNDM). The lawsuit alleges Tandem provided the public with material information regarding...

Sep 08, 2023 06:09 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tandem Diabetes Care, Inc. Securities and Sets a Lead Plaintiff Deadlin

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) between August 3, 2022 and...

Aug 24, 2023 04:05 pm ET

Tandem Diabetes Care Announces Upcoming Conference Presentations

Aug 03, 2023 04:06 pm ET

Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced a limited time offer for its Tandem Choice technology access program. This program provides new and renewing, eligible t:slim X2 Insulin Pump (t:slim X2) customers in the United States a pathway to ownership of the Tandem Mobi System (Tandem Mobi) for $199. The Tandem Mobi was recently cleared by the United States Food and Drug Administration to be used as a part of an automated insulin delivery system and a limited launch is expected to begin later this year with general avai

Aug 03, 2023 04:02 pm ET

Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2023 and updated its financial guidance for the year ending December 31, 2023.

You are here

Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution